Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:3086094rdf:typepubmed:Citationlld:pubmed
pubmed-article:3086094lifeskim:mentionsumls-concept:C0036025lld:lifeskim
pubmed-article:3086094lifeskim:mentionsumls-concept:C0043393lld:lifeskim
pubmed-article:3086094lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:3086094lifeskim:mentionsumls-concept:C0025516lld:lifeskim
pubmed-article:3086094lifeskim:mentionsumls-concept:C0025519lld:lifeskim
pubmed-article:3086094lifeskim:mentionsumls-concept:C0040005lld:lifeskim
pubmed-article:3086094lifeskim:mentionsumls-concept:C0150543lld:lifeskim
pubmed-article:3086094lifeskim:mentionsumls-concept:C0699900lld:lifeskim
pubmed-article:3086094pubmed:issue2lld:pubmed
pubmed-article:3086094pubmed:dateCreated1986-7-18lld:pubmed
pubmed-article:3086094pubmed:abstractTextL-Threonine catabolism by Saccharomyces cerevisiae was studied to determine the role of glycolytic bypath as a detoxyfication system of 2-oxoaldehyde (methylglyoxal) formed from L-threonine catabolism. During the growth on L-threonine as a sole source of nitrogen, a large amount of aminoacetone was accumulated in the culture. The enzymatic analyses indicated that L-threonine was converted into either acetaldehyde and glycine by threonine aldolase or 2-aminoacetoacetate by NAD-dependent threonine dehydrogenase. Glycine formed was condensed with acetyl-CoA by aminoacetone synthase to form 2-aminoacetoacetate, a labile compound spontaneously decarboxylated into aminoacetone. The enzyme activities of the glycolytic bypath of the cells grown on L-threonine were considerably higher than those of the cells grown on ammonium sulfate as a nitrogen source. The result indicated the possible role of glycolytic bypath as a detoxification system of methylglyoxal formed from L-threonine catabolism.lld:pubmed
pubmed-article:3086094pubmed:languageenglld:pubmed
pubmed-article:3086094pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3086094pubmed:citationSubsetIMlld:pubmed
pubmed-article:3086094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3086094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3086094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3086094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3086094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3086094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3086094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3086094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3086094pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:3086094pubmed:statusMEDLINElld:pubmed
pubmed-article:3086094pubmed:monthJunlld:pubmed
pubmed-article:3086094pubmed:issn0014-2956lld:pubmed
pubmed-article:3086094pubmed:authorpubmed-author:InoueYYlld:pubmed
pubmed-article:3086094pubmed:authorpubmed-author:WatanabeKKlld:pubmed
pubmed-article:3086094pubmed:authorpubmed-author:FukudaYYlld:pubmed
pubmed-article:3086094pubmed:authorpubmed-author:KimuraAAlld:pubmed
pubmed-article:3086094pubmed:authorpubmed-author:MurataKKlld:pubmed
pubmed-article:3086094pubmed:authorpubmed-author:ShimosakaMMlld:pubmed
pubmed-article:3086094pubmed:authorpubmed-author:SaikusaTTlld:pubmed
pubmed-article:3086094pubmed:issnTypePrintlld:pubmed
pubmed-article:3086094pubmed:day2lld:pubmed
pubmed-article:3086094pubmed:volume157lld:pubmed
pubmed-article:3086094pubmed:ownerNLMlld:pubmed
pubmed-article:3086094pubmed:authorsCompleteYlld:pubmed
pubmed-article:3086094pubmed:pagination297-301lld:pubmed
pubmed-article:3086094pubmed:dateRevised2007-7-23lld:pubmed
pubmed-article:3086094pubmed:meshHeadingpubmed-meshheading:3086094-...lld:pubmed
pubmed-article:3086094pubmed:meshHeadingpubmed-meshheading:3086094-...lld:pubmed
pubmed-article:3086094pubmed:meshHeadingpubmed-meshheading:3086094-...lld:pubmed
pubmed-article:3086094pubmed:meshHeadingpubmed-meshheading:3086094-...lld:pubmed
pubmed-article:3086094pubmed:meshHeadingpubmed-meshheading:3086094-...lld:pubmed
pubmed-article:3086094pubmed:meshHeadingpubmed-meshheading:3086094-...lld:pubmed
pubmed-article:3086094pubmed:meshHeadingpubmed-meshheading:3086094-...lld:pubmed
pubmed-article:3086094pubmed:meshHeadingpubmed-meshheading:3086094-...lld:pubmed
pubmed-article:3086094pubmed:meshHeadingpubmed-meshheading:3086094-...lld:pubmed
pubmed-article:3086094pubmed:meshHeadingpubmed-meshheading:3086094-...lld:pubmed
pubmed-article:3086094pubmed:meshHeadingpubmed-meshheading:3086094-...lld:pubmed
pubmed-article:3086094pubmed:year1986lld:pubmed
pubmed-article:3086094pubmed:articleTitleMetabolism of 2-oxoaldehydes in yeasts. Possible role of glycolytic bypath as a detoxification system in L-threonine catabolism by Saccharomyces cerevisiae.lld:pubmed
pubmed-article:3086094pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:3086094pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:856665entrezgene:pubmedpubmed-article:3086094lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:3086094lld:pubmed